Russotti Gregory 4
4 · Century Therapeutics, Inc. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) CTO Gregory Russotti Sells 10,076 Shares
What Happened
- Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics (IPSC), sold 10,076 shares on March 12, 2026. The shares were disposed at $2.55 each, netting $25,684.
- The filing notes these sales were automatic to satisfy tax withholding obligations on vested restricted stock units (RSUs) and were not at the Reporting Person's discretion — a routine, administrative sale rather than an expressed market view.
Key Details
- Transaction date: 2026-03-12; sale price: $2.55 per share; total proceeds: $25,684.
- Transaction type: Sale (shares sold to cover tax withholding on RSU vesting).
- Footnote: Sales were automatic to cover tax withholding (not discretionary).
- Filing date: 2026-03-16. (The transaction occurred March 12; Form 4s are typically due within two business days — review the filing page for any late-filing flag.)
- Shares owned after the transaction: not specified in the excerpt provided.
Context
- Sales to cover tax withholding on RSU vesting are common and generally administrative; they do not necessarily indicate the insider's sentiment about the company's prospects.
- This was not an options exercise or a voluntary open-market sale; it was a cashless/automatic disposition solely for tax withholding purposes.
Insider Transaction Report
Form 4
Russotti Gregory
See Remarks
Transactions
- Sale
Common Stock
[F1]2026-03-12$2.55/sh−10,076$25,684→ 515,427 total
Holdings
- 92,773(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Signature
/s/ Douglas Carr, Attorney-in-Fact|2026-03-16